公开(公告)号：US11723930B2

公开(公告)日：2023-08-15

申请号：US16752326

申请日：2020-01-24

申请人： CELULARITY, INC.

发明人： James W. Edinger ,  Robert J. Hariri ,  Jia-Lun Wang ,  Qian Ye ,  Herbert Faleck

IPC分类号： A61K35/50 ,  A61K45/06 ,  A61K35/644 ,  A61K38/21 ,  C12N5/073 ,  A61K35/12

CPC分类号： A61K35/50 ,  A61K35/644 ,  A61K38/21 ,  A61K45/06 ,  C12N5/0605 ,  A61K2035/122 ,  C12N2500/25 ,  C12N2500/36 ,  C12N2501/11 ,  C12N2501/135 ,  C12N2501/39 ,  A61K35/644 ,  A61K2300/00 ,  A61K35/50 ,  A61K2300/00 ,  A61K38/21 ,  A61K2300/00

摘要： Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.